WP
GMED icon

WealthShield Partners’s Globus Medical GMED Stock Holding History

WealthShield Partners’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-183
Closed -$11K – 919
2021
Q1 		$11K Buy
+183
New +$11.6K ﹤0.01% 780

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

WealthShield Partners's GMED Position: Q2 2021 in Review

WealthShield Partners sold out of Globus Medical (GMED) in Q2 2021, closing a stake of 183 shares — an estimated $11K sold.

WealthShield Partners first reported a position in GMED in Q1 2021 and held it in 1 quarter. The position peaked at $11K in Q1 2021. 354 funds tracked by Wall St. Rank hold GMED as of Q2 2021.

  • WealthShield Partners reported no remaining Globus Medical position as of Q2 2021 after selling out during the quarter.
  • WealthShield Partners sold 183 Globus Medical shares in Q2 2021, an estimated $11K.
  • WealthShield Partners first reported a position in Globus Medical in Q1 2021 and held it in 1 quarter.
  • WealthShield Partners's Globus Medical position peaked at $11K in Q1 2021.
  • 354 funds tracked by Wall St. Rank held Globus Medical as of Q2 2021.

Based on WealthShield Partners's 13F filing for Q2 2021, filed 6 Aug 2021.